TRP_1170x120_3-8-19

EnvisionRx

Strategy to build a new Rite Aid takes shape

Strategy to build a new Rite Aid takes shape

CAMP HILL, Pa. — Rite Aid Corp. president and chief operating officer Kermit Crawford said he’s confident the company “will succeed in building the new Rite Aid” following its $4.375 billion asset sale to Walgreens Boots Alliance (WBA). Under the deal, announced in September, Rite Aid is selling 1,932 stores, three distribution centers and related

Rite Aid’s health care assets offer options

Rite Aid’s health care assets offer options

Investments made in recent years put Rite Aid in a better position to rebound from the terminated deal to be acquired by Walgreens Boots Alliance. Rite Aid’s acquisitions of retail clinic operator RediClinic, health care management specialist Health Dialog and pharmacy benefit manager EnvisionRx give it more options as its leadership considers the company’s future

Rite Aid finishes fiscal year on positive note

Rite Aid finishes fiscal year on positive note

CAMP HILL, Pa. — Despite declines in net income, Rite Aid Corp. posted increased sales and exceeded Wall Street’s adjusted earnings per share forecast for its fiscal 2017 fourth quarter and year. Chairman and chief executive officer John Standley, however, noted that the ongoing regulatory review of Rite Aid’s deal to be acquired by Walgreens

Costco inks 90-day scripts pact with Rite Aid’s EnvisionRx

Costco inks 90-day scripts pact with Rite Aid’s EnvisionRx

TWINSBURG, Ohio, and ISSAQUAH, Wash. — Costco Wholesale Corp. plans to offer a 90-day maintenance medication program through its pharmacies under an agreement with EnvisionRx, a pharmacy benefit management subsidiary of Rite Aid Corp. The companies said Thursday that Costco will participate in EnvisionRx’s Rx90 prescription drug program. Rx90 enables patients to fill 90-day prescriptions

EnvisionRx, Walgreens team up on 90-day scripts

DEERFIELD, Ill. — Walgreens and EnvisionRx are launching a prescription drug program that is designed to give patients with chronic conditions more flexibility in getting their maintenance medications. Called Rx90, the program allows patients to fill 90-day prescriptions at any of the nearly 8,200 Walgreens pharmacies nationwide for the same price they would pay for

Walgreens adds EnvisionRx’s Rx90 drug plan

Walgreens adds EnvisionRx’s Rx90 drug plan

DEERFIELD, Ill. — Walgreens and EnvisionRx are launching a new prescription drug program called Rx90 that is designed to give patients with chronic conditions more flexibility in getting their maintenance medications. The program allows patients to fill 90-day prescriptions at any of the nearly 8,200 Walgreens pharmacies nationwide, for the same price they would pay

Prime Therapeutics teams up with WBA

Prime Therapeutics teams up with WBA

DEERFIELD, Ill. — The partnership of Walgreens Boots Alliance Inc. (WBA) and pharmacy benefit manager Prime Therapeutics positions the companies to capture a larger share of the prescription drug market and better compete with such players as CVS Health. St. Paul, Minn.-based Prime, the nation’s fourth-largest PBM with 22 million members, is owned by 14

Rite Aid, PBM division introduce Rx90

CAMP HILL, Pa. — Rite Aid Corp. and EnvisionRx, the pharmacy benefit management division of EnvisionRxOptions and a wholly owned subsidiary of Rite Aid, have debuted Rx90, a new program focused on improving medication adherence and health outcomes for consumers with chronic conditions. Rx90, now available for EnvisionRx clients, gives consumers the option to fill

Rite Aid, EnvisionRx start 90-day at retail program

Rite Aid, EnvisionRx start 90-day at retail program

CAMP HILL, Pa. — A new prescription drug program from Rite Aid Corp. and its EnvisionRx pharmacy benefit management arm gives patients with chronic conditions more flexibility in getting their maintenance medications. Called Rx90, the program enables patients to fill 90-day prescriptions at any of Rite Aid’s nearly 4,600 pharmacies or, for the same price,

Rite Aid turns in net loss for first quarter

Rite Aid turns in net loss for first quarter

CAMP HILL, Pa. — Rite Aid Corp. cited pressure in pharmacy reimbursement as it reported a net loss and fell short of Wall Street’s earnings forecast for its fiscal 2017 first quarter. Meanwhile, overall retail sales and same-store sales edged up for the quarter, and the EnvisionRx pharmacy benefit management business, acquired about a year

Rite Aid finishes fiscal 2016 on an up note

Rite Aid finishes fiscal 2016 on an up note

CAMP HILL, Pa. — Boosted by its acquisition of EnvisionRx, Rite Aid Corp. saw sales rise for its fiscal 2016 fourth quarter and full year, with adjusted earnings per share topping Wall Street estimates for both periods. Rite Aid said Thursday that for the fourth quarter ended Feb. 27, sales totaled $8.27 billion, up 20.8%

Rite Aid ready to do a lot more than fill scripts

Rite Aid ready to do a lot more than fill scripts

CAMP HILL, Pa. — With its recent acquisitions, Rite Aid Corp. is well-positioned to further expand its health care capabilities, according to chairman and chief executive officer John Standley. The company in June closed the $2 billion acquisition of Envision Pharmaceutical Services, which brought the EnvisionRx pharmacy benefit manager (PBM) as well as specialty pharmacy,

Rite Aid has come a long way

Rite Aid has come a long way

CAMP HILL, Pa. — It’s been an impressive journey for Rite Aid Corp. Not long ago, Rite Aid was a struggling drug chain, laden with debt and unable to keep pace with larger, fast-growing competitors. But today, under a firmer financial footing, the $26.5 billion company stands as a profitable, innovative industry leader, widening its

New structure reflects transformation of Rite Aid

New structure reflects transformation of Rite Aid

CAMP HILL, Pa. — A new chapter opened for Rite Aid Corp. in its fiscal 2016 second quarter, as the company began reporting financial results under a new structure that incorporates recently acquired pharmacy benefit manager (PBM) EnvisionRx. Going forward, Rite Aid will report results in two business segments: retail pharmacy (including Rite Aid drug